Exploratory scaffold hopping strategies led to identification of novel histamine H3 and H4 receptor ligands

Introduction Histamine H 3 and H 4 receptors (H 3 R and H 4 R) have been explored as attractive targets for the treatment of neuropsychological and inflammatory conditions, respectively, due to their expression profiles and involvement in the pathophysiological mechanisms of these conditions. Although these receptors share high structural similarity, selective ligands are frequently reported in the literature. Generally, H 3 R/H 4 R ligands share a common chemotype containing an aromatic region and a basic moiety bridged by a variable linker group. Our group has been exploring this chemotype to identify novel H 3 R/H 4 R ligands, with a particular focus on the LINS01 and LINS05 series, which showed nanomolar affinity. Methods In this work a scaffold hopping strategy was used to identify novel structural frameworks that bind to these receptors and to provide new data regarding the structure-activity relationships (SAR) of H 3 R/H 4 R ligands. Two sets of compounds were designed from known H 3 R/H 4 R prototypes using ring opening, homologation and bioisosterism strategies; these compounds were synthesized and assessed for their affinity at H 3 R/H 4 R. Results The LINS05 set led to identification of compounds with micromolar to submicromolar affinity toward H 3 R and selectivity over H 4 R, among which compound 7 (pKi 6.27) was the most potent. The compounds from LINS01 set mostly showed nanomolar affinities to H 3 R, with compound 11 being the most potent and selective toward H 3 R (pKi 7.02), while compound 14 was the most potent for H 4 R (pKi H 4 R 5.23; H 3 R 6.27). Docking experiments were carried out to analyze the potential interactions that these compounds may perform with the receptors and to rationalize the role of each structural modifications on the binding affinities. Conclusion In summary, the results added important SAR data to the H 3 R/H 4 R field, and novel prototypes were identified for further optimization.

Authors

Institutions

Publication Details

Journal
Frontiers in Drug Discovery
Published
2026-09-14
DOI
https://doi.org/10.3389/fddsv.2026.1944403
Primary Topic
Mast cells and histamine
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Exploratory scaffold hopping strategies led to identification of novel histamine H3 and H4 receptor ligands

Denise Mönnich, Steffen Pockes, Flavia B. Lopes, João Paulo S. Fernandes et al.
Frontiers in Drug Discovery
Mast cells and histamine
article

Exploratory scaffold hopping strategies led to identification of novel histamine H3 and H4 receptor ligands

Denise Mönnich, Steffen Pockes, Flavia B. Lopes, João Paulo S. Fernandes, Gustavo A. B. Fernandes
article en

Abstract

Introduction Histamine H 3 and H 4 receptors (H 3 R and H 4 R) have been explored as attractive targets for the treatment of neuropsychological and inflammatory conditions, respectively, due to their expression profiles and involvement in the pathophysiological mechanisms of these conditions. Although these receptors share high structural similarity, selective ligands are frequently reported in the literature. Generally, H 3 R/H 4 R ligands share a common chemotype containing an aromatic region and a basic moiety bridged by a variable linker group. Our group has been exploring this chemotype to identify novel H 3 R/H 4 R ligands, with a particular focus on the LINS01 and LINS05 series, which showed nanomolar affinity. Methods In this work a scaffold hopping strategy was used to identify novel structural frameworks that bind to these receptors and to provide new data regarding the structure-activity relationships (SAR) of H 3 R/H 4 R ligands. Two sets of compounds were designed from known H 3 R/H 4 R prototypes using ring opening, homologation and bioisosterism strategies; these compounds were synthesized and assessed for their affinity at H 3 R/H 4 R. Results The LINS05 set led to identification of compounds with micromolar to submicromolar affinity toward H 3 R and selectivity over H 4 R, among which compound 7 (pKi 6.27) was the most potent. The compounds from LINS01 set mostly showed nanomolar affinities to H 3 R, with compound 11 being the most potent and selective toward H 3 R (pKi 7.02), while compound 14 was the most potent for H 4 R (pKi H 4 R 5.23; H 3 R 6.27). Docking experiments were carried out to analyze the potential interactions that these compounds may perform with the receptors and to rationalize the role of each structural modifications on the binding affinities. Conclusion In summary, the results added important SAR data to the H 3 R/H 4 R field, and novel prototypes were identified for further optimization.

Frontiers in Drug DiscoveryVol. 6
University of Regensburg (DE), Universidade Federal de São Paulo (BR)
Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Openalex Percentile: Top 18%
Mast cells and histamine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.